G. Helmchen et al.
FULL PAPER
(5.61 g, 61%) as colorless needles. M.p. 158–160°C. [α]2D1 = –124.5
7.55–7.62 (m, 2 H, Ph-Ho), 7.64–7.71 (m, 2 H, Ph-Ho). 13C NMR
1
(c = 1.94, CHCl3). H NMR (300 MHz, CDCl3): δ = 1.12 (s, 3 H, (CDCl3): δ = 21.80 (q, C-8), 23.35 (dd, JC,P = 7.9 Hz, CHP), 26.85
8-H), 1.14 (s, 3 H, 9-H), 1.24 (d, J7a,7b = 9.9 Hz, 1 H, 7-Ha), 1.83 (q, C-9), 27.46, 27.49 [2q, NC(CH3)2], 28.70 (td, JC,P = 2.8 Hz, C-
(dddd, J = 19.9, J = 14.0, J = 5.5, J = 3.0 Hz, 1 H, 4-Ha), 1.96– 7), 30.70 (td, JC,P = 18.1 Hz, C-4), 38.81 (d, JC,P = 2.3 Hz, C-6),
2.60 (m, 2 H, 1-H, 5-H), 2.34–2.43 (m, 2 H, 4-Hb, 7-Hb), 2.42, 2.55 40.95 (dd, JC,P = 2.2 Hz, C-5), 42.88 (dd, JC,P = 20.4 Hz, C-2),
[2bs, each 3 H, N(CH3)2], 2.98 (ddd, J2,P = 16.5, J = 6.5, J = 1.8
Hz, 1 H, 2-H), 3.86–3.97 (m, 1 H, CHP), 7.20–7.25 (m, 3 H, Ph-
44.14 (dd, JC,P = 3.4 Hz, C-1), 66.46 [s, NC(CH3)2], 78.63 (t,
CH2O), 127.55 (dd, JC,P = 7.4 Hz, Ph-Cm), 128.24 (dd, JC,P = 6.8
H
m,p), 7.30–7.40 (m, 3 H, Ph-Hm,p), 7.49–7.58 (m, 2 H, Ph-Ho), Hz, Ph-Cm), 128.49 (d, Ph-Cp), 128.85 (dd, JC,P = 1.1 Hz, Ph-Cp),
7.63–7.70 (m, 2 H, Ph-Ho). 13C NMR (CDCl3): δ = 22.43 (q, C-8),
133.81 (dd, JC,P = 18.6 Hz, Ph-Co), 134.70 (d, JC,P = 19.2 Hz, Ph-
Co), 137.20 (d, JC,P = 13.5 Hz, Ph-Ci), 137.48 (d, JC,P = 17.0 Hz,
Ph-Ci), 167.39 (d, JC,P = 5.0 Hz, C=N). 31P NMR (CDCl3): δ =
23.55 (dd, JC,P = 5.5 Hz, CHP), 27.58 (q, C-9), 31.48 (td, JC,P
22.1 Hz, C-4), 31.90 (t, C-7), 35.51, 36.33 [2bq, N(CH3)2], 38.83
=
(d, JC,P = 1.7 Hz, C-6), 41.51 (dd, JC,P = 4.0 Hz, C-5), 44.19 (dd, +9.6 (13b), δ = +37.5 (13b-oxide). C26H32NOP (405.56): calcd. C
JC,P = 4.5 Hz, C-1), 46.73 (dd, JC,P = 20.3 Hz, C-2), 127.29 (dd, 76.99, H 7.97, N 3.45, P 7.64; found C 76.81, H 7.94, N 2.32, P
JC,P = 7.9 Hz, Ph-Cm), 128.11 (dd, JC,P = 6.8 Hz, Ph-Cm), 128.49 7.71.
(d, Ph-Cp), 128.85 (dd, JC,P = 1.1 Hz, Ph-Cp), 133.09 (dd, JC,P
=
(–)-2-[(1S,2R,3S)-Diphenylphosphanyl-6,6-dimethylbicyclo[3.1.1]-
hept-2-yl]-(4R)-phenyl-4,5-dihydro-1,3-oxazol (13c): Dihydroox-
azole 7c (2.90 g, 10.8 mmol) was reacted with diphenylphosphane
according to GP 2. In the course of the reaction the product pre-
cipitated and acetonitrile (15 mL) was added to allow stirring. The
solid obtained after work-up (ca. 4.3 g) was suspended in n-hexane
(20 mL) under reflux, followed by slow addition of ethyl acetate
until a clear solution was obtained. Upon slow cooling in an oil
bath 2.60 g of 13c precipitated. Further crystallization from the
mother liquid yielded additional 1.31 g of 13c (80% overall yield)
as thick needles. M.p. 118–120°C. [α]2D0 = –47.6 (c = 0.90, CHCl3).
1H NMR (300 MHz, CDCl3): δ = 1.04 (s, 3 H, 8-H), 1.21 (s, 3 H,
9-H), 1.69 (d, J7a,7b = 10.1 Hz, 1 H, 7-Ha), 1.83 (dddd, J = 19.8, J
= 14.0, J = 3.7, J = 3.7 Hz, 1 H, 4-Ha), 1.96–2.03 (m, 1 H, 5-H),
2.28–2.55 (m, 3 H, 1-H, 4-Hb, 7-Hb), 3.08–3.19 (m, 1 H, 2-H), 3.73
18.1 Hz, Ph-Co), 134.65 (dd, JC,P = 20.3 Hz, Ph-Co), 137.11 (d, JC,P
= 15.8 Hz, Ph-Ci), 137.31 (d, JC,P = 14.1 Hz, Ph-Ci), 172.80 (d,
JC,P = 2.3 Hz, C=O). 31P NMR (CDCl3): δ = +8.1 (12), δ = +35.8
(12-oxide). C24H30NOP (379.52): calcd. C 75.95, H 7.98, N 3.69, P
8.16; found C 75.89, H 7.99, N 3.61, P 8.20.
(–)-2-[(1S,2R,3S)-3-Diphenylphosphanyl-6,6-dimethylbicyclo[3.1.1]-
hept-2-yl]-4,5-dihydro-1,3-oxazole (13a): Dihydrooxazole 7a (2.75 g,
14.4 mmol) was reacted with diphenylphosphane according to GP
2. Under argon, the crude oil obtained after work-up was dissolved
in diethyl ether and filtered. The product crystallized upon standing
at 5°C for several days to give 13a (3.30 g, 58%) as large, octahe-
1
dral crystals. M.p. 102–104°C. [α]2D1 = –88.7 (c = 1.76, CHCl3). H
NMR (300 MHz, CDCl3): δ = 1.02 (s, 3 H, 8-H), 1.15 (s, 3 H, 9-
H), 1.36 (d, J7a,7b = 8.8 Hz, 1 H, 7-Ha), 1.80 (dddd, J = 18.2, J =
14.2, J = 4.1, J = 4.1 Hz, 1 H, 4-Ha), 1.92–1.98 (m, 1 H, 5-H), (dd, J = 9.6, J = 8.3 Hz, 1 H, CH2O), 3.76–3.86 (m, 1 H, CHP),
2.27–2.43 (m, 3 H, 1-H, 4-Hb, 7-Hb), 2.84–2.96 (m, 1 H, 2-H), 3.26–
3.39 (m, 1 H, CH2N), 3.49–3.61 (m, 1 H, CH2N), 3.63–3.73 (m, 1
H, CHP), 3.78 (td, J = 10.5, J = 8.1 Hz, 1 H, CH2O), 3.91 (td, J
= 10.3, J = 8.0 Hz, 1 H, CH2O), 7.18–7.25 (m, 3 H, Ph-Hm,p), 7.30–
7.41 (m, 3 H, Ph-Hm,p), 7.50–7.57 (m, 2 H, Ph-Ho), 7.64–7.71 (m,
2 H, Ph-Ho). 13C NMR (CDCl3): δ = 21.54 (q, C-8), 24.19 (dd,
JC,P = 8.5 Hz, CHP), 26.98 (q, C-9), 29.73 (td, JC,P = 1.7 Hz, C-
7), 30.94 (td, JC,P = 18.0 Hz, C-4), 38.79 (d, JC,P = 2.2 Hz, C-6),
41.00 (dd, JC,P = 2.2 Hz, C-5), 43.00 (dd, JC,P = 20.8 Hz, C-2),
4.39 (dd, J = 9.9, J = 8.4 Hz, 1 H, CH2O), 4.97 (t, J = 9.8 Hz, 1
H, CHN), 6.89–6.94 (m, 2 H, Ph-H), 7.17–7.33 (m, 6 H, Ph-H),
7.34–7.42 (m, 3 H, Ph-H), 7.56–7.66 (m, 2 H, Ph-Ho), 7.68–7.72
(m, 2H Ph-Ho). 13C NMR (CDCl3): δ = 21.21 (q, C-8), 23.81 (dd,
JC,P = 9.0 Hz, CHP), 26.83 (q, C-9), 28.25 (td, JC,P = 4.5 Hz, C-
7), 30.65 (td, JC,P = 17.0 Hz, C-4), 38.78 (d, JC,P = 2.3 Hz, C-6),
40.82 (dd, JC,P = 1.7 Hz, C-5), 42.35 (dd, JC,P = 20.4 Hz, C-2),
44.27 (dd, JC,P = 2.8 Hz, C-1), 69.41 (d, CHN), 74.26 (t, CH2O),
126.81, 127.21 (2d, Ph-C), 127.99 (dd, JC,P = 6.8 Hz, Ph-Cm),
43.96 (dd, JC,P = 4.0 Hz, C-1), 53.75 (t, CH2N), 66.59 (t, CH2O), 128.32 (dd, JC,P = 6.8 Hz, Ph-Cm), 128.49 (d, Ph-C), 128.75 (dd,
127.41 (dd, JC,P = 7.4 Hz, Ph-Cm), 128.32 (dd, JC,P = 6.8 Hz, Ph-
Cm), 128.69 (dd, JC,P = 1.1 Hz, Ph-Cp), 128.79 (d, Ph-Cp), 133.75
JC,P = 1.1 Hz, Ph-Cp), 128.80 (d, Ph-Cp), 133.93 (d, JC,P = 18.6
Hz, Ph-Co), 134.50 (dd, JC,P = 19.8 Hz, Ph-Co), 137.11 (d, JC,P
=
(dd, JC,P = 18.6 Hz, Ph-Co), 134.64 (dd, JC,P = 19.2 Hz, Ph-Co), 13.6 Hz, Ph-Ci), 137.58 (d, JC,P = 17.5 Hz, Ph-Ci), 142.00 (s, Ph-
136.84 (d, JC,P = 13.5 Hz, Ph-Ci), 137.40 (d, JC,P = 16.4 Hz, Ph-
C), 170.98 (d, JC,P = 5.6 Hz, C=N). 31P NMR (CDCl3): δ = +9.2
Ci), 169.91 (d, JC,P = 4.0 Hz, C=N). 31P NMR(CDCl3): δ = +7.8 (13c), δ = +37.8 (13c-oxide). C30H32NOP (453.60): calcd. C 79.43,
(13a), δ = +36.6 (13a-oxide). C24H28NOP (377.50): calcd. C 76.35, H 7.13, N 3.09, P 6.83; found C 79.21, H 7.22, N 3.03, P 6.76.
H 7.49, N 3.71, P 8.20; found C 76.21, H 7.52, N 3.61, P 8.10.
(–)-2-[(1S,2R,3S)-3-Diphenylphosphanyl-6,6-dimethylbicyclo-
(–)-2-[(1S,2R,3S)-3-Diphenylphosphanyl-6,6-dimethylbicyclo-
[3.1.1]hept-2-yl]-4,4-dimethyl-4,5-dihydro-1,3-oxazole (13b): Dihy-
drooxazole 7b (3.82 g, 17.4 mmol) was reacted with diphenylphos-
phane according to GP 2. The oil obtained after work-up crys-
tallized upon standing. The product was purified by suspending the
crystals at –78°C under argon in a small amount of n-hexane. The
residue was dissolved in diethyl ether, filtered and the solvent was
removed to give 13b (4.33 g, 61%) as needles. M.p. 91–92°C. [α]2D0
[3.1.1]hept-2-yl]-(4S)-phenyl-4,5-dihydro-1,3-oxazole (13d): Dihy-
drooxazole 7d (390 mg, 1.46 mmol) was reacted with diphenylphos-
phane according to GP 2. After work-up, an oily mixture of dia-
stereomers, 13c/13d = 20:1 (398 mg, 60%) was obtained. [α]2D0
=
–47.4 (c = 1.00, CHCl3). 1H NMR (300 MHz, CDCl3): δ = 1.12 (s,
3 H, 8-H), 1.20 (s, 3 H, 9-H), 1.42 (d, J7a,7b = 9.6 Hz, 1 H, 7-Ha),
1.78–1.88 (m, 1 H, 4-Ha), 1.96–2.03 (m, 1 H, 5-H), 2.33–2.53 (m,
3 H, 1-H, 4-Hb, 7-Hb), 2.93–3.37 (m, 1 H, 2-H), 3.65 (t, J = 8.5
Hz, 1 H, CH2O), 3.73–3.86 (m, 1 H, CHP), 4.15 (dd, J = 10.3, J
= 8.1 Hz, 1 H, CH2O), 4.60–4.69 (m, 1 H, CHN), 7.04–7.08 (m, 2
1
= –77.8 (c = 2.62, CHCl3). H NMR (300 MHz, CDCl3): δ = 0.94
[s, 3 H, NC(CH3)2], 0.99 (s, 3 H, 8-H), 1.07 [s, 3 H, NC(CH3)2],
1.16 (s, 3 H, 9-H), 1.55 (d, J7a,7b = 9.5 Hz, 1 H, 7-Ha), 1.78 (dddd, H, Ph-H), 7.24–7.40 (m, 9 H, Ph-H), 7.58–7.64 (m, 2 H, Ph-H),
J = 20.2, J = 14.0, J = 3.7, J = 3.7 Hz, 1 H, 4-Ha), 1.92–1.98 (m,
7.66–7.71 (m, 2 H, Ph-H). 13C NMR (CDCl3): δ = 22.15 (q, C-8),
1 H, 5-H), 2.27–2.43 (m, 3 H, 1-H, 4-Hb, 7-Hb), 2.92 (ddd, J2,P 24.17 (dd, JC,P = 8.4 Hz, CHP), 27.11 (q, C-9), 30.06 (td, JC,P
17.6 Hz J = 4.8 Hz J = 2.6 Hz, 1 H, 2-H), 3.48 (d, J = 7.7 Hz, 1 2.2 Hz, C-7), 31.20 (td, JC,P = 18.6 Hz, C-4), 39.06 (d, JC,P = 2.2
=
=
H, CH2O), 3.62 (d, J = 7.7 Hz, 1 H, CH2O), 3.60–3.74 (m, 1 H, Hz, C-6), 41.34 (dd, JC,P = 1.7 Hz, C-5), 43.51 (dd, JC,P = 20.9 Hz,
CHP), 7.18–7.25 (m, 3 H, Ph-Hm,p), 7.30–7.41 (m, 3 H, Ph-Hm,p), C-2), 44.58 (dd, JC,P = 3.4 Hz, C-1), 69.64 (d, CHN), 74.07 (t,
3256
© 2005 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
Eur. J. Org. Chem. 2005, 3246–3262